Medafor
Medafor develops novel hemostatic technology and absorbable hemostats called MPH(R), which accelerates the normal blood clotting process.
Business Model:
Revenue: $23.8M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Medafor Information
Medafor was acquired by
C. R. Bard.
The acquisition happend on 2013-08-19.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 2700 Freeway Blvd
City: Minneapolis
State: MN
Zip: 55430
Country: US
Financial Info
Stage:
seed
Raised Last:
$15k
Raised Total:$115k
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Medafor, Inc. is a medical device company that has developed and commercialized a patented hemostatic agent that has been shown to enhance and accelerate the normal blood clotting process. Medafor’s MPH technology is unparalleled in terms of safety, efficacy, and cost.
Contact Phone:
+17635716300
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2012 | Seed Round | $15k | 9/2009 | Convertible Note | $100k |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
